SUNPHARMA logo

SUN Pharmaceutical IND L

F&O
SUNPHARMA·NSE·
1,924.00 -5.00 (-0.26%)
Market Cap463572.65 Cr
PE Ratio40.22
Volume10,55,465
Day High - Low1948.50 - 1910.00
52W High-Low2046.90 - 1548.00
DocStoX Score
6.3/10
Fair
Fair Value
Sign in to see
ROE
16.00%
Strong
P/E
40.22x
Expensive
Debt / Equity
0.61
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 50NIFTY 100NIFTY 200
Day1910
1949
52W1548
2047
DocStoX take

Supported by growth (8.4) and risk (8.2), but held back by valuation (0.7). Growth looks strong at 8.4, but that is offset by valuation at 0.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.3
/10
Fair
Quality
Solid
ROE 16.0%
Valuation
Expensive
P/E 40.2×
Growth
Strong
Revenue +11.8% 5Y CAGR
Risk
Low risk
D/E 0.61
Momentum
Strong
75% of 52-week range

At a glance

Market Cap
₹4.64L Cr
52W High / Low
₹2047 / ₹1548
Dividend Yield
0.84%
Promoter Holding
54.48%
EPS (TTM)
₹47.84
Book Value
₹348.00

Key highlights

  • Profit compounding 38% a year
  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 21%
  • Valuation is weak (0.7/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

SUN PHARMACEUTICAL IND L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.